DrugPatentWatch Database Preview
Covidien Company Profile
What is the competitive landscape for COVIDIEN, and what generic and branded alternatives to COVIDIEN drugs are available?
COVIDIEN has one approved drug.
Summary for Covidien
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Covidien: | See patent lawsuits for Covidien |
Drugs and US Patents for Covidien
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Covidien | LYMPHAZURIN | isosulfan blue | INJECTABLE;INJECTION | 018310-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
